Immuron Limited logo
Immuron Limited IMRN
€ 0.76 12.82%

Geschäftsbericht 2022
hinzugefügt 09.09.2022

report update icon

Immuron Limited DIO 2011-2026 | IMRN

DIO Jährlich Immuron Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 1.32 K 2.33 K 2.53 K - - - - - -

Alle Zahlen in AUD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.53 K 1.32 K 2.06 K

DIO anderer Aktien in der Pharmaeinzelhändler

Name DIO Preis % 24h Marktkapitalisierung Land
Acorda Therapeutics Acorda Therapeutics
ACOR
345 - -24.86 % $ 820 K usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.89 $ 0.79 -1.15 % $ 4.31 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
512 - - $ 40.3 B usaUSA
ADMA Biologics ADMA Biologics
ADMA
316 $ 15.36 -2.17 % $ 3.66 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
40.6 - -18.52 % $ 27.3 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
275 - - - russiaRussia
Anika Therapeutics Anika Therapeutics
ANIK
247 $ 14.05 -1.44 % $ 206 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
181 $ 74.36 -1.64 % $ 1.44 B usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
63.8 - - $ 521 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
168 $ 162.43 0.6 % $ 8.08 B usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
892 $ 8.49 -0.18 % $ 1.75 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
233 $ 65.66 -0.78 % $ 12.6 B usaUSA
Acasti Pharma Acasti Pharma
ACST
136 - 4.01 % $ 150 M canadaCanada
BioDelivery Sciences International BioDelivery Sciences International
BDSI
321 - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
304 - 0.49 % $ 251 B cayman-islandsCayman-islands
Berkeley Lights Berkeley Lights
BLI
246 - -7.31 % $ 87 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
55.6 - 5.93 % $ 314 M canadaCanada
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
644 $ 61.3 1.21 % $ 11.8 B usaUSA
Codexis Codexis
CDXS
50.2 $ 1.23 -2.38 % $ 90.3 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
271 - -7.23 % $ 13 M usaUSA